China Pharma Holdings Price to Free Cash Flow Ratio 2010-2023 | CPHI
Historical price to free cash flow ratio values for China Pharma Holdings (CPHI) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
China Pharma Holdings Price to Free Cash Flow Ratio Historical Data |
Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
2024-05-02 |
0.30 |
|
0.00 |
2023-12-31 |
0.61 |
$-0.21 |
0.00 |
2023-09-30 |
0.74 |
$0.39 |
1.89 |
2023-06-30 |
1.71 |
$-0.16 |
0.00 |
2023-03-31 |
1.95 |
$-0.72 |
0.00 |
2022-12-31 |
4.80 |
$-0.77 |
0.00 |
2022-09-30 |
6.50 |
$-1.64 |
0.00 |
2022-06-30 |
10.73 |
$-2.60 |
0.00 |
2022-03-31 |
19.50 |
$-1.37 |
0.00 |
2021-12-31 |
24.13 |
$-0.75 |
0.00 |
2021-09-30 |
27.93 |
$-0.43 |
0.00 |
2021-06-30 |
36.16 |
$0.06 |
623.45 |
2021-03-31 |
42.00 |
$-1.35 |
0.00 |
2020-12-31 |
22.29 |
$-1.13 |
0.00 |
2020-06-30 |
33.32 |
$-0.69 |
0.00 |
2020-03-31 |
25.20 |
$0.22 |
115.20 |
2019-12-31 |
11.84 |
$0.54 |
21.85 |
2019-09-30 |
12.26 |
$-3.17 |
0.00 |
2019-06-30 |
16.17 |
$-2.72 |
0.00 |
2019-03-31 |
16.59 |
$-2.16 |
0.00 |
2020-09-30 |
18.24 |
$-2.29 |
0.00 |
2018-12-31 |
12.87 |
$2.10 |
6.13 |
2018-09-30 |
10.21 |
$2.11 |
4.83 |
2018-06-30 |
11.00 |
$1.86 |
5.90 |
2018-03-31 |
15.86 |
$1.42 |
11.13 |
2017-12-31 |
8.78 |
$0.81 |
10.86 |
2017-09-30 |
8.75 |
$1.38 |
6.33 |
2017-06-30 |
11.50 |
$1.59 |
7.22 |
2017-03-31 |
13.00 |
$0.02 |
546.22 |
2016-12-31 |
13.00 |
$2.71 |
4.80 |
2016-09-30 |
10.75 |
$2.43 |
4.43 |
2016-06-30 |
12.00 |
$0.62 |
19.44 |
2015-12-31 |
7.85 |
$3.06 |
2.57 |
2015-09-30 |
9.92 |
$-2.52 |
0.00 |
2015-06-30 |
18.00 |
$-2.35 |
0.00 |
2015-03-31 |
17.00 |
$-1.69 |
0.00 |
2014-12-31 |
15.01 |
$-2.63 |
0.00 |
2016-03-31 |
8.50 |
$-1.17 |
0.00 |
2014-09-30 |
12.55 |
$-7.93 |
0.00 |
2014-06-30 |
19.25 |
$-17.60 |
0.00 |
2014-03-31 |
25.25 |
$-13.96 |
0.00 |
2013-12-31 |
17.25 |
$-11.70 |
0.00 |
2013-09-30 |
14.00 |
$-6.38 |
0.00 |
2013-06-30 |
10.50 |
$3.51 |
2.99 |
2013-03-31 |
14.50 |
$3.41 |
4.25 |
2012-12-31 |
10.10 |
$2.15 |
4.70 |
2012-09-30 |
18.25 |
$1.87 |
9.76 |
2012-06-30 |
17.00 |
$3.82 |
4.45 |
2012-03-31 |
34.00 |
$3.64 |
9.35 |
2011-12-31 |
33.50 |
$5.62 |
5.96 |
2011-09-30 |
48.50 |
$8.03 |
6.04 |
2011-06-30 |
112.50 |
$9.12 |
12.34 |
2011-03-31 |
126.50 |
$9.17 |
13.79 |
2010-12-31 |
151.50 |
$8.87 |
17.08 |
2010-09-30 |
124.50 |
$11.92 |
10.44 |
2010-06-30 |
137.50 |
$12.75 |
10.79 |
2010-03-31 |
166.50 |
$12.97 |
12.84 |
2009-12-31 |
192.50 |
$12.45 |
15.46 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.004B |
$0.007B |
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|